1. Home
  2. RETO vs NKGN Comparison

RETO vs NKGN Comparison

Compare RETO & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RETO
  • NKGN
  • Stock Information
  • Founded
  • RETO 1999
  • NKGN 2017
  • Country
  • RETO China
  • NKGN United States
  • Employees
  • RETO N/A
  • NKGN N/A
  • Industry
  • RETO Multi-Sector Companies
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RETO Consumer Discretionary
  • NKGN Health Care
  • Exchange
  • RETO Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • RETO 19.9M
  • NKGN 22.6M
  • IPO Year
  • RETO 2017
  • NKGN N/A
  • Fundamental
  • Price
  • RETO $0.91
  • NKGN $0.44
  • Analyst Decision
  • RETO
  • NKGN
  • Analyst Count
  • RETO 0
  • NKGN 0
  • Target Price
  • RETO N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • RETO 16.2K
  • NKGN 438.4K
  • Earning Date
  • RETO 10-28-2024
  • NKGN 01-28-2025
  • Dividend Yield
  • RETO N/A
  • NKGN N/A
  • EPS Growth
  • RETO N/A
  • NKGN N/A
  • EPS
  • RETO N/A
  • NKGN N/A
  • Revenue
  • RETO $3,841,142.00
  • NKGN N/A
  • Revenue This Year
  • RETO N/A
  • NKGN N/A
  • Revenue Next Year
  • RETO N/A
  • NKGN N/A
  • P/E Ratio
  • RETO N/A
  • NKGN N/A
  • Revenue Growth
  • RETO N/A
  • NKGN N/A
  • 52 Week Low
  • RETO $0.84
  • NKGN $0.20
  • 52 Week High
  • RETO $5.00
  • NKGN $4.06
  • Technical
  • Relative Strength Index (RSI)
  • RETO 47.58
  • NKGN 40.80
  • Support Level
  • RETO $0.84
  • NKGN $0.45
  • Resistance Level
  • RETO $0.92
  • NKGN $0.53
  • Average True Range (ATR)
  • RETO 0.05
  • NKGN 0.10
  • MACD
  • RETO 0.00
  • NKGN -0.03
  • Stochastic Oscillator
  • RETO 64.60
  • NKGN 8.61

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: